Immunomedics Engages Greenhill & Co. as Strategic Advisor
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
UBS Raises Price Target on Greenhill & Co. (GHL) to $17; Reiterates Sell
October 25, 2016 9:10 AM EDTUBS reiterated a Sell rating on Greenhill & Co. (NYSE: GHL), and raised the price target to $17.00 (from $13.00), following the company's 3Q earnings report. GHL reported EPS of $0.41, missing consensus estimates of $0.42. 4Q16 EPS estimates go up by 43c to $0.53 due to a much higher near-term outlook for advisory revenue... More
